Browse Category

NYSE:XZO News 23 December 2025 - 2 January 2026

Exzeo (XZO) stock drops nearly 8% in New Year trading — what investors are watching next

Exzeo (XZO) stock drops nearly 8% in New Year trading — what investors are watching next

NEW YORK, Jan 2, 2026, 14:20 ET — Regular session Shares of Exzeo Group Inc slid on Friday, down $1.89, or about 7.8%, at $22.36 in afternoon trading. The NYSE-listed stock traded between $22.25 and $24.18, with about 164,000 shares changing hands. The move stood out on a relatively calm tape, as U.S. equities wobbled into the first full session of 2026 and investors reset positioning after year-end. Thin liquidity in newer listings can amplify swings even when the broader market is steady. Exzeo, founded in 2012, provides software and analytics tools that help property-and-casualty insurers streamline tasks such as
2 January 2026
Exzeo Group (XZO) stock steadies in premarket after Monday jump as Fed minutes loom

Exzeo Group (XZO) stock steadies in premarket after Monday jump as Fed minutes loom

NEW YORK, December 30, 2025, 07:16 ET — Premarket Shares of Exzeo Group, Inc. (XZO) were indicated flat at $23.32 in premarket trading, which takes place before the regular 9:30 a.m. ET open. The stock last traded at $23.16 after hours, down 0.7%. The newly listed insurance-technology firm has been sensitive to year-end liquidity, when thinner volumes can magnify moves. Exzeo went public on the New York Stock Exchange in November after raising $168 million in an initial public offering, with parent HCI Group retaining a majority stake. Reuters The broader backdrop was cautious. U.S. stock index futures were steady
Exzeo Group (NYSE: XZO) Stock Today: Price Action, Latest News, Analyst Targets, and What Investors Are Watching Into the Close

Exzeo Group (NYSE: XZO) Stock Today: Price Action, Latest News, Analyst Targets, and What Investors Are Watching Into the Close

As of 1:16 p.m. ET in New York on Friday, December 26, 2025, U.S. trading desks are back from the Christmas holiday to a market that’s quiet, thinly traded, and hovering near record territory—a classic setup where individual stocks can move sharply on relatively modest flows. AP News Exzeo Group, Inc. (NYSE: XZO) is firmly in that “new IPO with a developing story” category. Midday Friday, XZO is trading at about $22.14, down roughly 4.65% on the session, with an intraday range of $22.00 to $23.39. Below is what’s driving the conversation around Exzeo stock right now—covering the newest SEC
26 December 2025
Exzeo Group, Inc. (NYSE: XZO) Stock News on Dec. 23, 2025: Insider Buying, CEO 10b5‑1 Plan, and Wall Street Targets

Exzeo Group, Inc. (NYSE: XZO) Stock News on Dec. 23, 2025: Insider Buying, CEO 10b5‑1 Plan, and Wall Street Targets

Exzeo Group, Inc. stock (NYSE: XZO) is getting a classic “new IPO meets fresh filings” moment on Tuesday, December 23, 2025—the kind where the market wakes up, sees insiders buying, sees an SEC trading plan, sees compensation updates, and collectively decides: we should probably pay attention to this ticker again. By early afternoon, XZO was trading around $22.80 (+3.5%), after opening near $23.00—a move that followed multiple insider transaction disclosures and broader coverage buildout since the company’s November IPO. StockAnalysis+1 What moved XZO stock today: three insider purchases at the same price The headline driver on Dec. 23 is the
23 December 2025

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Go toTop